COVID-19: epidemiological update. Weekly report. Week 51. 30 December 2021.

Publié le 31 décembre 2021
Mis à jour le 5 janvier 2022

Key points

In week 51, the circulation of SARS-CoV-2 surged with strong growth in Omicron, which is now the dominant variant.

  • Metropolitan France:
    • Incidence rate* above 1,000/100,000 inhabitants in Île-de-France, Provence-Alpes-Côte d’Azur, Corsica, and Auvergne-Rhône-Alpes
    • Largest increase in the incidence rate* among 20-29 and 30-39 year-olds
    • New hospital and intensive care admissions stable but high at the national level with regional disparities
  • Overseas France:
    • Sharp rise in the incidence rate* in Guadeloupe and Mayotte
    • Incidence rate still very high in Reunion Island

Variants

  • 62.4% of screened tests showing a profile compatible with the Omicron variant at the start of week 52
  • Omicron representing 15% of interpretable sequences in the Flash Survey from week 50 (13 December)

Prevention

  • Vaccination on 28 December 2021 (Vaccin Covid data):
    • 77,0% of the French population had received a complete primary vaccination series
    • 43.7% of the 18+ age group (80.7% of eligible people) and 70.6% of the 65+ age group (87.9% of eligible people) had received a booster shot
  • Importance of combining different measures: complete vaccination schedule (including complete primary vaccination and booster shot after 3 months) as well as adherence to contact tracing and recommended guidelines
  • Compliance with preventive measures, including reducing contacts and frequently ventilating enclosed spaces, is essential during the end-of-year festive period given the circulation of the Omicron variant